The purpose of this study is to analyse the implementation of the Construction Products Regulation (EU) No 305/2011 (the CPR) in Member States as regards their legal provisions and administrative practices, as well as at the level of the whole EU.

The focus for this evaluation has been to review the overall activities, achievements and impacts of the current Sciencewise programme, which runs from April 2012 to March 2015, and to draw out lessons and opportunities for the future.

The purpose of this project is to establish the range of impacts and calculate the financial and economic damages which resulted from the 2013/14 winter floods.

The subject of the service is the quantification and valuation of the human health impacts of chemicals, based on quality-adjusted life-years (QALYs) and disability-adjusted life-years (DALYs) (and related concepts). The human health impacts of interest are those relevant to the chemicals which have been subject to previous REACH Annex XVII restrictions/restriction dossiers, which are listed in REACH Annex XIV or are on the 'Candidate List', or which are expected to be subject to restriction or prioritisation in the near future. Many of these chemicals are likely to be associated with health impacts which have already been subject to measurement using QALYs and DALYs.

RPA is one of the Framework Contractors providing advice to the Environment Agency for England and Wales on Economics.

RPA was contracted by the Polish chemical manufacturer Grupa Azoty S.A. to support the preparation of an application for the authorisation of the continued use of trichloroethylene (TCE, EC No.: 201-167-4, CAS No.: 79-01-6) in the manufacture of caprolactam in Grupa Azoty S.A.’s plant in Tarnow, Poland. For this project, RPA acted as a sub-contractor to its long-term partner on REACH Authorisation matters Forschungs- und Beratungsinstitut Gefahrstoffe GmbH (FoBiG).